ATEM Capital

ATEM Capital

United States; New York United States; New York New York United States; North America; Great Lakes; New York Metro
Is it you?
Investor info
Type
Venture Capital
Stage focus
  • Early stage VC,
  • Later stage VC,
  • Other
Geography focus
France; United States; Europe
Industry focus
Description
ATEM Capital is a New York-based venture capital firm investing in life sciences and biotechnology companies, with emphasis on innovations addressing unmet clinical need, strong IP protection and strategic relevance. It backs early-stage and later-stage opportunities across biotechnology, pharmaceuticals and HealthTech, with investment activity in the United States, Europe and France. Portfolio examples include Amolyt Pharma, Triumvira Immunologics, Arpeggio Biosciences, Atea Pharmaceuticals and Syndax Pharmaceuticals.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Biotechnology
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.